231 related articles for article (PubMed ID: 28783177)
1. Autophagy-dependent generation of Axin2+ cancer stem-like cells promotes hepatocarcinogenesis in liver cirrhosis.
Li J; Hu SB; Wang LY; Zhang X; Zhou X; Yang B; Li JH; Xiong J; Liu N; Li Y; Wu YZ; Zheng QC
Oncogene; 2017 Nov; 36(48):6725-6737. PubMed ID: 28783177
[TBL] [Abstract][Full Text] [Related]
2. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.
Wu K; Ding J; Chen C; Sun W; Ning BF; Wen W; Huang L; Han T; Yang W; Wang C; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
Hepatology; 2012 Dec; 56(6):2255-67. PubMed ID: 22898879
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis.
Kim WH; Matsumoto K; Bessho K; Nakamura T
Am J Pathol; 2005 Apr; 166(4):1017-28. PubMed ID: 15793283
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma.
Ning BF; Ding J; Yin C; Zhong W; Wu K; Zeng X; Yang W; Chen YX; Zhang JP; Zhang X; Wang HY; Xie WF
Cancer Res; 2010 Oct; 70(19):7640-51. PubMed ID: 20876809
[TBL] [Abstract][Full Text] [Related]
5. Identification of local and circulating cancer stem cells in human liver cancer.
Yang ZF; Ngai P; Ho DW; Yu WC; Ng MN; Lau CK; Li ML; Tam KH; Lam CT; Poon RT; Fan ST
Hepatology; 2008 Mar; 47(3):919-28. PubMed ID: 18275073
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis.
Corpechot C; Barbu V; Wendum D; Chignard N; Housset C; Poupon R; Rosmorduc O
Am J Pathol; 2002 Feb; 160(2):613-20. PubMed ID: 11839582
[TBL] [Abstract][Full Text] [Related]
7. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus PreS1 facilitates hepatocellular carcinoma development by promoting appearance and self-renewal of liver cancer stem cells.
Liu Z; Dai X; Wang T; Zhang C; Zhang W; Zhang W; Zhang Q; Wu K; Liu F; Liu Y; Wu J
Cancer Lett; 2017 Aug; 400():149-160. PubMed ID: 28455240
[TBL] [Abstract][Full Text] [Related]
9. C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.
Lim YC; Kang HJ; Moon JH
Oral Oncol; 2014 Jul; 50(7):633-9. PubMed ID: 24835851
[TBL] [Abstract][Full Text] [Related]
10. Expression of HGF, its receptor c-met, c-myc, and albumin in cirrhotic and neoplastic human liver tissue.
Ljubimova JY; Petrovic LM; Wilson SE; Geller SA; Demetriou AA
J Histochem Cytochem; 1997 Jan; 45(1):79-87. PubMed ID: 9010472
[TBL] [Abstract][Full Text] [Related]
11. BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.
Liu Q; Chen K; Liu Z; Huang Y; Zhao R; Wei L; Yu X; He J; Liu J; Qi J; Qin Y; Li B
Cancer Lett; 2017 Sep; 403():165-174. PubMed ID: 28645561
[TBL] [Abstract][Full Text] [Related]
12. Manipulating HGF signaling reshapes the cirrhotic liver niche and fills a therapeutic gap in regeneration mediated by transplanted stem cells.
Zhang H; Chen Q; Hu D; Lai J; Yan M; Wu Z; Yang Z; Zheng S; Liu W; Zhang L; Bai L
Exp Cell Res; 2024 Jan; 434(1):113867. PubMed ID: 38043723
[TBL] [Abstract][Full Text] [Related]
13. u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma.
Tavian D; De Petro G; Benetti A; Portolani N; Giulini SM; Barlati S
Int J Cancer; 2000 Sep; 87(5):644-9. PubMed ID: 10925356
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor/scatter factor enhances the thrombopoietin mRNA expression in rat hepatocytes and cirrhotic rat livers.
Yamashita K; Matsuoka H; Ochiai T; Matsushita R; Kubuki Y; Suzuki M; Tsubouchi H
J Gastroenterol Hepatol; 2000 Jan; 15(1):83-90. PubMed ID: 10719752
[TBL] [Abstract][Full Text] [Related]
15. Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer.
Chen WC; Chang YS; Hsu HP; Yen MC; Huang HL; Cho CY; Wang CY; Weng TY; Lai PT; Chen CS; Lin YJ; Lai MD
Oncotarget; 2015 Dec; 6(40):42923-37. PubMed ID: 26556861
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine.
Horiguchi N; Takayama H; Toyoda M; Otsuka T; Fukusato T; Merlino G; Takagi H; Mori M
Oncogene; 2002 Mar; 21(12):1791-9. PubMed ID: 11896611
[TBL] [Abstract][Full Text] [Related]
17. Stem-like cells in hepatitis B virus-associated cirrhotic livers and adjacent tissue to hepatocellular carcinomas possess the capacity of tumorigenicity.
Sun YL; Yin SY; Xie HY; Zhou L; Xue F; Wu LM; Gao F; Zheng SS
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1280-6. PubMed ID: 18466286
[TBL] [Abstract][Full Text] [Related]
18. Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway.
Zhao X; Fu J; Xu A; Yu L; Zhu J; Dai R; Su B; Luo T; Li N; Qin W; Wang B; Jiang J; Li S; Chen Y; Wang H
Cell Death Dis; 2015 May; 6(5):e1751. PubMed ID: 25950481
[TBL] [Abstract][Full Text] [Related]
19. Investigation of diagnostic utility and expression profiles of stem cell markers (CD133 and CD90) in hepatocellular carcinoma, small cell dysplasia, and cirrhosis.
Yilmaz G; Akyol G; Cakir A; Ilhan M
Pathol Res Pract; 2014 Jul; 210(7):419-25. PubMed ID: 24702884
[TBL] [Abstract][Full Text] [Related]
20. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.
Ching RHH; Sze KMF; Lau EYT; Chiu YT; Lee JMF; Ng IOL; Lee TKW
Oncotarget; 2017 Apr; 8(14):23507-23516. PubMed ID: 28186991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
